Can C-Reactive Protein Inform Antidepressant Medication Selection in Depressed Outpatients? Findings from the CO-MED Trial

Lignende værker

• Proteomics profiling of inflammation-related biomarkers in antidepressant treatment response: Findings from the CO-MED trial
  af: Gadad, Bharathi S., et al.
  Udgivet: (2017)
• Interleukin 17 Selectively Predicts Better Outcomes with Bupropion-SSRI Combination: Novel T Cell Biomarker for Antidepressant Medication Selection
  af: Jha, Manish K., et al.
  Udgivet: (2017)
• Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
  af: Jha, Manish K., et al.
  Udgivet: (2019)
• Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings from the CO-MED Trial
  af: Jha, Manish K., et al.
  Udgivet: (2016)
• Validating Pre-Treatment Body Mass Index as Moderator of Antidepressant Treatment Outcomes: Findings from CO-MED Trial
  af: Jha, Manish K., et al.
  Udgivet: (2018)